Success Metrics

Clinical Success Rate
93.3%

Based on 28 completed trials

Completion Rate
93%(28/30)
Active Trials
1(3%)
Results Posted
50%(14 trials)
Terminated
2(6%)

Phase Distribution

Ph phase_1
1
3%
Ph phase_2
1
3%
Ph not_applicable
1
3%
Ph phase_3
15
44%
Ph early_phase_1
1
3%
Ph phase_4
14
41%

Phase Distribution

2

Early Stage

1

Mid Stage

29

Late Stage

Phase Distribution33 total trials
Early Phase 1First-in-human
1(3.0%)
Phase 1Safety & dosage
1(3.0%)
Phase 2Efficacy & side effects
1(3.0%)
Phase 3Large-scale testing
15(45.5%)
Phase 4Post-market surveillance
14(42.4%)
N/ANon-phased studies
1(3.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.3%

28 of 30 finished

Non-Completion Rate

6.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

34

all time

Status Distribution
Active(1)
Completed(28)
Terminated(2)
Other(3)

Detailed Status

Completed28
unknown3
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
34
Active
1
Success Rate
93.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.0%)
Phase 11 (3.0%)
Phase 21 (3.0%)
Phase 315 (45.5%)
Phase 414 (42.4%)
N/A1 (3.0%)

Trials by Status

completed2882%
active_not_recruiting13%
terminated26%
unknown39%

Recent Activity

Clinical Trials (34)

Showing 20 of 34 trialsScroll for more
NCT04137107Phase 2

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Active Not Recruiting
NCT00071708

Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial

Unknown
NCT05508516Early Phase 1

Shugan Dingtong Decoction in the Treatment of Fibromyalgia

Completed
NCT01598298Phase 3

S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

Completed
NCT03395353Phase 3

A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder

Terminated
NCT03315793Phase 3

A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder

Completed
NCT00489411Phase 3

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Completed
NCT03110172Phase 1

Short-term Efficacy of Antidepressant in Patients Underwent TKA

Unknown
NCT00960986Phase 4

A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder

Completed
NCT00422162Phase 4

A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

Completed
NCT00408993Phase 3

Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China

Completed
NCT00385671Phase 4

An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain

Completed
NCT00810069Phase 4

Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder

Completed
NCT00641719Phase 3

A Long-term Study for the Treatment of Painful Diabetic Neuropathy

Completed
NCT00406848Phase 4

A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients

Completed
NCT00437125Phase 4

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

Completed
NCT00673452Phase 4

A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia

Completed
NCT00536471Phase 4

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Completed
NCT00491348Not Applicable

Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI Study

Terminated
NCT00583193Phase 3

Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
34